EC Sanction of DuoCort's Plenadren Triggers ViroPharma's $33M Acquisition of ... Genetic Engineering News EC approval of DuoCort's Plenadren® (hydrocortisone modified release tablet) therapy for adrenal insufficiency in adults marks the go-ahead for ViroPharma to acquire the Swedish specialty pharma firm. The definitive agreement for ViroPharma to acquire ... DuoCort Pharma's Orphan Drug Plenadren® Granted European Marketing ... DuoCort adrenal insufficiency drug OK'd in Europe DuoCort Pharma granted marketing authorization for adrenal insufficiency drug ... |
